Denmark - Danish - Lægemiddelstyrelsen (Danish Medicines Agency)

zentiva k.s. - bisoprololfumarat - tabletter - 1,25 mg

Denmark - Danish - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - natriumnitroprussiddihydrat - pulver til infusionsvæske, opløsning - 60 mg

European Union - Danish - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacciner - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. brug af denne vaccine bør være i overensstemmelse med de officielle anbefalinger.

Denmark - Danish - Lægemiddelstyrelsen (Danish Medicines Agency)

s.a.l.f. s.p.a. - calciumchloriddihydrat, histidin, histidinhydrochloridmonohydrat, kaliumchlorid, magnesiumchloridhexahydrat, mannitol, natriumchlorid, tryptophan - opløsning til kardioplegi

Denmark - Danish - Lægemiddelstyrelsen (Danish Medicines Agency)

actavis group ptc ehf. - ibuprofen - filmovertrukne tabletter - 200 mg

Denmark - Danish - Lægemiddelstyrelsen (Danish Medicines Agency)

stada arzneimittel ag - hydrochlorthiazid, valsartan - filmovertrukne tabletter - 160+12,5 mg

Denmark - Danish - Lægemiddelstyrelsen (Danish Medicines Agency)

stada arzneimittel ag - hydrochlorthiazid, valsartan - filmovertrukne tabletter - 160+25 mg

Denmark - Danish - SEGES Landbrug & Fødevarer

adama northern europe b.v. - uspecificeret - flydende middel - 0 g/l uspecificeret

Denmark - Danish - Lægemiddelstyrelsen (Danish Medicines Agency)

mylan hospital as - cefotaximnatrium - pulver til injektions-/infusionsvæske, opløsning - 2 g

Denmark - Danish - Lægemiddelstyrelsen (Danish Medicines Agency)

mylan hospital as - cefotaximnatrium - pulver til injektionsvæske, opløsning - 1 g